Scott D. Nash

2.6k total citations
98 papers, 1.7k citations indexed

About

Scott D. Nash is a scholar working on Physiology, Microbiology and Otorhinolaryngology. According to data from OpenAlex, Scott D. Nash has authored 98 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Physiology, 42 papers in Microbiology and 32 papers in Otorhinolaryngology. Recurrent topics in Scott D. Nash's work include Reproductive tract infections research (42 papers), Sinusitis and nasal conditions (32 papers) and Allergic Rhinitis and Sensitization (26 papers). Scott D. Nash is often cited by papers focused on Reproductive tract infections research (42 papers), Sinusitis and nasal conditions (32 papers) and Allergic Rhinitis and Sensitization (26 papers). Scott D. Nash collaborates with scholars based in United States, Ethiopia and France. Scott D. Nash's co-authors include Karen J. Cruickshanks, Ronald Klein, A. Wesley Burks, Robert A. Wood, Justin M. Skripak, Nga Brereton, Hannah Rowley, Robert G. Hamilton, Susan Oh and Elizabeth C. Matsui and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and American Journal of Public Health.

In The Last Decade

Scott D. Nash

89 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott D. Nash United States	18	579	524	338	334	298	98	1.7k
Melissa A. Pynnonen United States	19	188 0.3×	293 0.6×	91 0.3×	51 0.2×	47 0.2×	48	1.6k
David L. Witsell United States	22	438 0.8×	948 1.8×	543 1.6×	25 0.1×	90 0.3×	72	3.3k
Frans Gordts Belgium	18	191 0.3×	292 0.6×	298 0.9×	11 0.0×	97 0.3×	54	1.4k
Benjamin Volovitz Israel	24	282 0.5×	1.0k 2.0×	55 0.2×	76 0.2×	43 0.1×	77	2.2k
Helen Van Hoecke Belgium	15	182 0.3×	187 0.4×	279 0.8×	13 0.0×	71 0.2×	42	1.1k
Greg E. Davis United States	16	99 0.2×	95 0.2×	118 0.3×	39 0.1×	79 0.3×	49	986
Francesco Maria Passàli Italy	21	317 0.5×	415 0.8×	113 0.3×	9 0.0×	26 0.1×	101	1.5k
Anders Cervin Sweden	24	597 1.0×	669 1.3×	123 0.4×	63 0.2×	8 0.0×	81	1.8k
Harvey Coates Australia	26	13 0.0×	281 0.5×	168 0.5×	214 0.6×	195 0.7×	72	1.9k
Cheri A. Swenson United States	18	454 0.8×	1.9k 3.6×	38 0.1×	29 0.1×	34 0.1×	30	2.5k

Countries citing papers authored by Scott D. Nash

Since Specialization

Citations

This map shows the geographic impact of Scott D. Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Nash more than expected).

Fields of papers citing papers by Scott D. Nash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott D. Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Nash. The network helps show where Scott D. Nash may publish in the future.

Co-authorship network of co-authors of Scott D. Nash

This figure shows the co-authorship network connecting the top 25 collaborators of Scott D. Nash. A scholar is included among the top collaborators of Scott D. Nash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott D. Nash. Scott D. Nash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goodhew, E. Brook, Eshetu Sata, Andrew W. Nute, et al.. (2025). Prevalence of ocular Chlamydia trachomatis infection and antibodies within districts persistently endemic for trachoma, Amhara, Ethiopia. PLoS neglected tropical diseases. 19(3). e0012900–e0012900.

Fokkens, Wytske J., Claus Bachert, Claire Hopkins, et al.. (2024). Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial. Clinical & Translational Immunology. 13(6). e1511–e1511. 2 indexed citations

Aragie, Solomon, Eshetu Sata, Tàye Zeru, et al.. (2024). Compliance with tetracycline eye ointment during annual mass drug administration for trachoma control in the Amhara region, Ethiopia. Tropical Medicine & International Health. 29(10). 869–874.

Sata, Eshetu, Phong V. V. Le, Andrew W. Nute, et al.. (2024). Correlates of Trachoma Recrudescence: Results from 51 District-Level Trachoma Surveillance Surveys in Amhara, Ethiopia. Tropical Medicine and Infectious Disease. 9(12). 298–298. 1 indexed citations

Bachert, Claus, Asif Khan, Wytske J. Fokkens, et al.. (2024). Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP. Journal of Allergy and Clinical Immunology. 154(6). 1442–1449. 3 indexed citations

Lane, Andrew P., Joaquim Mullol, Claire Hopkins, et al.. (2024). Dupilumab improves sense of smell and clinical outcomes in patients with severe chronic rhinosinusitis with nasal polyps with anosmia. Current Medical Research and Opinion. 41(1). 53–59. 1 indexed citations

Han, Joseph K., Tanya M. Laidlaw, Anju T. Peters, et al.. (2024). Baseline Use of Oral Corticosteroids Among Patients With Chronic Rhinosinusitis With Nasal Polyps Enrolled In The Global AROMA Registry. Journal of Allergy and Clinical Immunology. 153(2). AB251–AB251. 1 indexed citations

Sata, Eshetu, Phong V. V. Le, Mulat Zerihun, et al.. (2024). Wait and watch: A trachoma surveillance strategy from Amhara region, Ethiopia. PLoS neglected tropical diseases. 18(2). e0011986–e0011986. 5 indexed citations

Máspero, Jorge, Asif Khan, Carl Philpott, et al.. (2023). Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial. Journal of Asthma and Allergy. Volume 16. 323–332. 9 indexed citations

10.

Tedijanto, Christine, Solomon Aragie, Sarah Gwyn, et al.. (2023). Seroreversion to Chlamydia trachomatis Pgp3 Antigen Among Children in a Hyperendemic Region of Amhara, Ethiopia. The Journal of Infectious Diseases. 230(2). 293–297. 1 indexed citations

11.

Gevaert, Philippe, Stella E. Lee, Russell A. Settipane, et al.. (2023). Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps. Clinical & Translational Immunology. 12(1). e1433–e1433. 7 indexed citations

12.

Nash, Scott D., Paul Weiss, Andrew W. Nute, et al.. (2023). Prevalence of Ocular Chlamydia trachomatis Infection in Amhara Region, Ethiopia, after 8 Years of Trachoma Control Interventions. American Journal of Tropical Medicine and Hygiene. 108(2). 261–267. 8 indexed citations

13.

Bachert, Claus, Asif Khan, Stella E. Lee, et al.. (2023). Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐52. International Forum of Allergy & Rhinology. 14(3). 668–678. 15 indexed citations

14.

Borlase, Anna, Seth Blumberg, E. Kelly Callahan, et al.. (2021). Modelling trachoma post-2020: opportunities for mitigating the impact of COVID-19 and accelerating progress towards elimination. Transactions of the Royal Society of Tropical Medicine and Hygiene. 115(3). 213–221. 14 indexed citations

15.

Astale, Tigist, Andrew W. Nute, Mulat Zerihun, et al.. (2021). The population-based prevalence of trachomatous scarring in a trachoma hyperendemic setting: results from 152 impact surveys in Amhara, Ethiopia. BMC Ophthalmology. 21(1). 213–213. 7 indexed citations

16.

Aragie, Solomon, Jason Melo, Mahteme Haile, et al.. (2021). Changing hygiene behaviours: a cluster-randomized trial, Ethiopia. Bulletin of the World Health Organization. 99(11). 762–772. 7 indexed citations

17.

Pickering, Harry, Eshetu Sata, Mulat Zerihun, et al.. (2020). Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, Ethiopia. The Journal of Infectious Diseases. 225(6). 994–1004. 11 indexed citations

18.

Nash, Scott D., Jeanne Moncada, Aisha E. P. Stewart, et al.. (2020). Ocular Chlamydia trachomatis infection and infectious load among pre-school aged children within trachoma hyperendemic districts receiving the SAFE strategy, Amhara region, Ethiopia. PLoS neglected tropical diseases. 14(5). e0008226–e0008226. 24 indexed citations

19.

Astale, Tigist, Eshetu Sata, Mulat Zerihun, et al.. (2018). Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia. PLoS neglected tropical diseases. 12(2). e0006270–e0006270. 22 indexed citations

20.

Nash, Scott D., Karen J. Cruickshanks, Ronald Klein, et al.. (2011). The Prevalence of Hearing Impairment and Associated Risk Factors. Archives of Otolaryngology - Head and Neck Surgery. 137(5). 432–432. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact